Altogether, these data confirmed the strong correlation between STARD3 and HER2 DNA amplification and RNA expression in breast cancer and prompted us to examine STARD3 protein expression in a clinical series by IHC using a specific anti-STARD3 antibody. The gene discussed is STARD3; the disease is breast carcinoma.